Corcept Therapeutics Shares Outstanding 2006-2019 | CORT

Corcept Therapeutics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2019 123
2018 127
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
2008 47
2007 34
2006 23
2005 23
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31 123
2019-09-30 122
2019-06-30 122
2019-03-31 124
2018-12-31 127
2018-09-30 126
2018-06-30 128
2018-03-31 128
2017-12-31 125
2017-09-30 126
2017-06-30 123
2017-03-31 121
2016-12-31 116
2016-09-30 116
2016-06-30 115
2016-03-31 110
2015-12-31 107
2015-09-30 108
2015-06-30 108
2015-03-31 102
2014-12-31 101
2014-09-30 101
2014-06-30 101
2014-03-31 101
2013-12-31 100
2013-09-30 100
2013-06-30 100
2013-03-31 100
2012-12-31 93
2012-09-30 99
2012-06-30 89
2012-03-31 84
2011-12-31 83
2011-09-30 84
2011-06-30 84
2011-03-31 81
2010-12-31 68
2010-09-30 72
2010-06-30 66
2010-03-31 63
2009-12-31 52
2009-09-30 50
2009-06-30 50
2009-03-31 50
2008-12-31 47
2008-09-30 49
2008-06-30 48
2008-03-31 40
2007-12-31 34
2007-09-30 37
2007-06-30 35
2007-03-31 26
2006-12-31 23
2006-09-30 23
2006-06-30 23
2006-03-31 23
2005-12-31 23
2005-09-30 23
2005-06-30 23
2005-03-31 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.246B $0.306B
Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $53.083B 30.71
Takeda Pharmaceutical (TAK) Japan $48.710B 8.54
Astellas Pharma (ALPMY) Japan $28.984B 14.48
Eisai (ESALY) Japan $20.745B 38.65
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.198B 17.65
Merck (MKGAF) Germany $13.006B 17.06
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.172B 227.03
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.163B 29.47
Ionis Pharmaceuticals (IONS) United States $6.879B 20.85
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.480B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.443B 6.64
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.553B 0.00
IPSEN SA ADR (IPSEY) France $4.515B 0.00
United Therapeutics (UTHR) United States $4.008B 0.00
Hypermarcas (HYPMY) Brazil $3.914B 11.90
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.059B 0.00
FibroGen (FGEN) United States $2.945B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.859B 53.06
PTC Therapeutics (PTCT) United States $2.527B 0.00
ChemoCentryx (CCXI) United States $2.376B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.271B 9.19
Sage Therapeutics (SAGE) United States $1.635B 0.00
Xencor (XNCR) United States $1.621B 66.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.613B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.550B 18.85
Pacira Pharmaceuticals (PCRX) United States $1.334B 36.47
Theravance Biopharma (TBPH) Cayman Islands $1.331B 0.00
Karyopharm Therapeutics (KPTI) United States $1.283B 0.00
USANA Health Sciences (USNA) United States $1.279B 13.43
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Zogenix (ZGNX) United States $1.060B 0.00
Heron Therapeutics (HRTX) United States $1.021B 0.00
Esperion Therapeutics (ESPR) United States $0.971B 0.00
Tilray (TLRY) Canada $0.947B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 29.03
Akebia Therapeutics (AKBA) United States $0.916B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.898B 12.50
Endo (ENDP) Ireland $0.787B 1.45
Translate Bio (TBIO) United States $0.649B 0.00
ImmunoGen (IMGN) United States $0.645B 0.00
Molecular Templates (MTEM) United States $0.645B 0.00
Radius Health (RDUS) United States $0.608B 0.00
Aerie Pharmaceuticals (AERI) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Portola Pharmaceuticals (PTLA) United States $0.536B 0.00
Indivior (INVVY) United States $0.480B 2.85
Catalyst Pharmaceuticals (CPRX) United States $0.390B 13.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Siga Technologies (SIGA) United States $0.384B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.378B 15.51
Corbus Pharmaceuticals Holdings (CRBP) United States $0.377B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Ardelyx (ARDX) United States $0.368B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.356B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.339B 0.00
Trillium Therapeutics (TRIL) Canada $0.328B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
Calithera Biosciences (CALA) United States $0.311B 0.00
DURECT (DRRX) United States $0.305B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.295B 0.00
TherapeuticsMD (TXMD) United States $0.293B 0.00
Lannett Co Inc (LCI) United States $0.292B 4.71
Harpoon Therapeutics (HARP) United States $0.286B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.265B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.263B 0.00
Ocular Therapeutix (OCUL) United States $0.259B 0.00
CASI Pharmaceuticals (CASI) United States $0.206B 0.00
OptiNose (OPTN) United States $0.184B 0.00
Rafael Holdings (RFL) United States $0.183B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 2.90
Recro Pharma (REPH) United States $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.152B 19.10
PROFOUND MEDICL (PROF) Canada $0.146B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Taiwan Liposome (TLC) Taiwan $0.139B 0.00
KalVista Pharmaceuticals (KALV) United States $0.130B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.119B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.099B 0.00
Redhill Biopharma (RDHL) Israel $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.086B 0.00
IMV INC (IMV) Canada $0.084B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.081B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Xeris Pharmaceuticals (XERS) United States $0.077B 0.00
Aquestive Therapeutics (AQST) United States $0.077B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
Otonomy (OTIC) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 16.43
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
MediWound (MDWD) Israel $0.045B 0.00
Onconova Therapeutics (ONTX) United States $0.044B 0.00
PharmAthene (ALT) United States $0.044B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.043B 19.41
Neos Therapeutics (NEOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.14
Forward Pharma (FWP) Denmark $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Heat Biologics (HTBX) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.05
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Novan (NOVN) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
China SXT Pharmaceuticals (SXTC) China $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
ElectroCore (ECOR) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00